Skip to main content
NCBI home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
editorial
. 1981 Mar 28;282(6269):1013. doi: 10.1136/bmj.282.6269.1013

Beta 2-microglobulin in haematological malignancies.

PMCID: PMC1504900  PMID: 6163499

Full text

PDF

Page 1013

1013

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amlot P. L., Adinolfi M. Serum beta 2 microglobulin and its prognostic value in lymphomas. Eur J Cancer. 1979 May;15(5):791–796. doi: 10.1016/0014-2964(79)90155-5. [DOI] [PubMed] [Google Scholar]
  2. Child J. A., Spati B., Illingworth S., Barnard D., Corbett S., Simmons A. V., Stone J., Worthy T. S., Cooper E. H. Serum beta 2 microglobulin and C-reactive protein in the monitoring of lymphomas: findings in a multicenter study and experience in selected patients. Cancer. 1980 Jan 15;45(2):318–326. doi: 10.1002/1097-0142(19800115)45:2<318::aid-cncr2820450220>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  3. Durie B. G., Salmon S. E. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer. 1975 Sep;36(3):842–854. doi: 10.1002/1097-0142(197509)36:3<842::aid-cncr2820360303>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  4. Ellegaard J., Mogensen C. E., Kragballe K. Serum beta 2-microglobulin in acute and chronic leukaemia. Scand J Haematol. 1980 Sep;25(3):275–285. doi: 10.1111/j.1600-0609.1981.tb01401.x. [DOI] [PubMed] [Google Scholar]
  5. Engström W., Hyldahl L., Wahrgren P. Urinary excretion of beta 2-microglobulin in myeloma patients. Clin Chim Acta. 1980 Dec 22;108(3):369–374. doi: 10.1016/0009-8981(80)90343-5. [DOI] [PubMed] [Google Scholar]
  6. Karlsson F. A., Wibell L., Evrin P. E. beta 2-Microglobulin in clinical medicine. Scand J Clin Lab Invest Suppl. 1980;154:27–37. [PubMed] [Google Scholar]
  7. Mavlight G. M., Stuckey S. E., Cabanillas F. F., Keating M. J., Tourtellotte W. W., Schold S. C., Freireich E. J. Diagnosis of leukemia or lymphoma in the central nervous system by beta 2-microglobulin determination. N Engl J Med. 1980 Sep 25;303(13):718–722. doi: 10.1056/NEJM198009253031302. [DOI] [PubMed] [Google Scholar]
  8. Morell A., Riesen W. Serum beta 2-microglobulin, serum creatinine and bone marrow plasma cells in benign and malignant monoclonal gammopathy. Acta Haematol. 1980;64(2):87–93. doi: 10.1159/000207216. [DOI] [PubMed] [Google Scholar]
  9. Norfolk D., Child J. A., Cooper E. H., Kerruish S., Ward A. M. Serum beta 2-microglobulin in myelomatosis: potential value in stratification and monitoring. Br J Cancer. 1980 Oct;42(4):510–515. doi: 10.1038/bjc.1980.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Rashid S. A., Cooper E. H., Axon A. T., Eaves G. Serum beta 2-microglobulin in malignant and benign diseases of the stomach and pancreas. Biomedicine. 1980 Jul-Aug;33(4):112–116. [PubMed] [Google Scholar]
  11. Simonsson B., Wibell L., Nilsson K. Beta 2-microglobulin in chronic lymphocytic leukaemia. Scand J Haematol. 1980 Feb;24(2):174–180. doi: 10.1111/j.1600-0609.1980.tb02364.x. [DOI] [PubMed] [Google Scholar]
  12. Späti B., Child J. A., Kerruish S. M., Cooper E. H. Behaviour of serum beta 2-microglobulin and acute phase reactant proteins in chronic lymphocytic leukaemia. A multicentre study. Acta Haematol. 1980;64(2):79–86. doi: 10.1159/000207215. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES